Coronary Stents Market Research Report - Global Forecast till 2027

Coronary Stents Market Research Report: by Products (Drug Eluting Stents, Bare Metal Stents, and Bioresorbable Vascular Scaffolds), By End-Users (Hospitals and clinics, ambulatory surgical center, specialty center, and others) - Forecast Till 2027

ID: MRFR/MED/5473-HCR | February 2021 | Region: Global | 130 pages

Impact of COVID – 19 on Coronary Stents Market:


An estimated two million people get coronary artery stents every year, according to the Harvard Health School. The current outbreak of COVID - 19 has affected the coronary stents market in several ways. The business complexities arising from the current pandemic has created confusion with respect to the production of medical devices. The solution to various multifaceted uncertainties experienced by coronary stent manufacturers, hospitals, surgical centers, and organizations working in the supply chain of these medical devices are covered in the restructured research report.


Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), well-defined data of all cardiac, thoracic, and vascular surgery procedures performed in 78 German heart surgery departments during the year 2018 were analyzed. For this period, a total of 174,902 procedures were submitted to the registry, 98,707 summarized as heart surgery procedures and 942 assist device implantations were registered. The growth in the cardiac surgeries can be explained with the help of infographic below.
below


Source: German Heart Surgery Report, German Society for Thoracic and Cardiovascular Surgery, MRFR Analysis


Impact of COVID-19 outbreak on cardiac surgery and coronary stent implants:


According to the PCROnline, cardiac surgery practice might not be on the frontline of COVID-19 patient care. However, the pandemic affects cardiac surgery units and coronary stent implants in several ways:



  • Limited intensive care unit (ICU) beds and ventilation sites

  • Necessity to postpone elective and/or complex cardiac surgeries

  • Shortage of healthcare workers

  • Restrictions in clinical meetings (e.g. limiting the number of attendees in heart-team meetings)

  • Patients with COVID-19 needing urgent cardiac operations

  • Cancelation of training and education, professional conferences, exams, and courses


Impact of COVID-19 outbreak on supply chain:


The disruption of the coronary stents market due to COVID-19 outbreak in select geographies is explained below. Procurement and supply of the raw materials, such as platinum and cobalt, required to produce stents have been affected due to a smaller number of freights operating between different continents. Many medical device manufacturing giants have headquarters and manufacturing facilities in different countries, which might lead to supply chain constraints. For instance, Boston Scientific’s headquarters in the US is supported by its manufacturing plants in the US, Ireland, and Malaysia to supply products around the globe.


The inventory of coronary stents by subsidiary companies in different countries are affected. For instance, due to reduced demand for coronary stent implant, the stock of products is not being sold. On the other hand, a subsidiary without manufacturing facility in respective country when imports the coronary stents for the patients, it increases the product cost and overall cost of procedures in select geographies.


Impact of COVID-19 outbreak due to delayed elective surgeries:


The focus of healthcare providers is primarily on the diagnosis and treatment of patients suffering from coronavirus. An urge from various national and regional governments to delay the elective surgeries has reduced the number of overall surgeries. The demand for medical devices is expected to shrink due to deferred elective surgeries.



  • Massachusetts General Hospital has announced hospital-wide cancellations of all elective surgeries starting March 23 until further notice.



  • The American College of Surgeons and the US surgeon general recommend that consideration be given to canceling elective surgeries countrywide.



  • Atlanta’s Gastroenterology Associates, which has backing from private equity firm Frazier Healthcare Partners, furloughed about 300 of its more than 800 employees after cutting elective surgeries, which account for nearly 80% of procedures.



  • The number of primary angioplasties, the main treatment for heart attack, dropped by 40% in Spain since the beginning of the lockdown.



  • In Jayadeva Hospital, Mysuru, an average of 40 to 50 patients used to undergo angiogram and 15 to 20 people were being installed stent per day. But now, hardly 10 to 15 people undergo angiogram and six patients are being installed stent since the lockdown.


The supply chain constraints coupled with delayed elective surgeries has affected the coronary stents market negatively. The government regulations affecting the coronary stents market are expected to inspire manufacturers take strategic decisions in respective countries.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Coronary Stents Market, by Products

6.1 Introduction

6.2 Drug Eluting Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Bare Metal Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Bioresorbable Vascular Scaffolds

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Coronary Stents Market, By End-User

7.1 Introduction

7.2 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Specialty Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Coronary Stents Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Abbott

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 B. Braun Melsungen AG

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Biotronik SE & Co. KG

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Boston Scientific Corporation

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 C. R. Bard, Inc.

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Cook Medical

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Elixir Medical Corporation

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Medtronic plc

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Meril Life Sciences

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 MicroPort Scientific Corporation

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Stentys SA

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.10 Terumo Corporation

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Coronary Stents Market Industry

Chapter 12. Appendix


LIST OF TABLES

Table 1 Global Coronary Stents Market Synopsis, 2020-2027

Table 2 Global Coronary Stents Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 4 Global Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 5 Global Coronary Stents Market, by Region, 2020-2027(USD Million)

Table 6 North America: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 7 North America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 8 North America: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 9 US: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 10 US: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 11 US: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 12 Canada: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 13 Canada: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 14 Canada: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 15 South America: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 16 South America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 17 South America: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 18 Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 19 Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 20 Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 21 Western Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 22 Western Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 23 Western Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 24 Eastern Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 25 Eastern Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 26 Eastern Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 27 Asia-Pacific: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 30 Middle East & Africa: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Coronary Stents Market, by Region, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Coronary Stents Market

Figure 3 Segmentation Market Dynamics for Global Coronary Stents Market

Figure 4 Global Coronary Stents Market Share, by Product, 2020 (%)

Figure 5 Global Coronary Stents Market Share, by End-User, 2020 (%)

Figure 6 Global Coronary Stents Market Share, by Region, 2020 (%)

Figure 7 North America: Coronary Stents Market Share, by Country, 2020 (%)

Figure 8 Europe: Coronary Stents Market Share, by Country, 2020 (%)

Figure 9 Asia-Pacific: Coronary Stents Market Share, by Country, 2020 (%)

Figure 10 Middle East & Africa: Coronary Stents Market Share, by Country, 2020 (%)

Figure 11 Global Coronary Stents Market: Company Share Analysis, 2020 (%)

Figure 12 Abbott: Key Financials

Figure 13 Abbott: Segmental Revenue

Figure 14 Abbott: Geographical Revenue

Figure 15 B. Braun Melsungen AG: Key Financials

Figure 16 B. Braun Melsungen AG: Segmental Revenue

Figure 17 B. Braun Melsungen AG: Geographical Revenue

Figure 18 Biotronik SE & Co. KG: Key Financials

Figure 19 Biotronik SE & Co. KG: Segmental Revenue

Figure 20 Biotronik SE & Co. KG: Geographical Revenue

Figure 21 Boston Scientific Corporation: Key Financials

Figure 22 Boston Scientific Corporation: Segmental Revenue

Figure 23 Boston Scientific Corporation: Geographical Revenue

Figure 24 C. R. BARD, INC.: Key Financials

Figure 25 C. R. BARD, INC.: Segmental Revenue

Figure 26 C. R. BARD, INC.: Geographical Revenue

Figure 27 Cook Medical: Key Financials

Figure 28 Cook Medical: Segmental Revenue

Figure 29 Cook Medical: Geographical Revenue

Figure 30 Elixir Medical Corporation: Key Financials

Figure 31 Elixir Medical Corporation: Segmental Revenue

Figure 32 Elixir Medical Corporation: Geographical Revenue

Figure 33 Medtronic plc: Key Financials

Figure 34 Medtronic plc: Segmental Revenue

Figure 35 Medtronic plc: Geographical Revenue

Figure 36 Meril Life Sciences: Key Financials

Figure 37 Meril Life Sciences: Segmental Revenue

Figure 38 Meril Life Sciences: Geographical Revenue

Figure 39 MicroPort Scientific Corporation: Key Financials

Figure 40 MicroPort Scientific Corporation: Segmental Revenue

Figure 41 MicroPort Scientific Corporation: Geographical Revenue

Figure 42 Stentys SA: Key Financials

Figure 43 Stentys SA: Segmental Revenue

Figure 44 Stentys SA: Geographical Revenue

Figure 45 Terumo Corporation: Key Financials

Figure 46 Terumo Corporation: Segmental Revenue

Figure 47 Terumo Corporation: Geographical Revenue